1Latin IR,Anand S,Masson S,et al.C-reactive protein in 4 202 patients with moderate to severe heart failure in Val-HeFT.Eur J Heart Fail (Suppl),2004,3:112-114.
2Anand IS,Latini R,Masson S,et al.C-Reactive Protein in Heart Failure Prognostic Value and the Effect of Valsartan.Circulation,2005,112:1428-1434.
3Anand IS,Yen J,Florea VG,et al.Prognostic role of neutrophil and lymphocyte counts in heart failure:results from Val-HeFT.Program and abstracts from the American College of Cardiology 53rd Annual Scientific Session;March7-10,2004;New Orleans,Louisiana.Abstract,1163-121.
4Higuchi Y,Mctierna CF,Frye CB,et al.Tumor necrosis factor receptors 1 and 2 differentially regulate survival,cardiac dysfunction,and remodeling in transgenic mice with tumor necrosis factor-alpha induced cardiomyopathy.Circulation,2004,109:1892-1897.
5Ikeda U,Shinada K Nitricoxide and cardiac failure.Clin Cardiol,1997,20:837-841.
7Kerydiyyeh SI,Abou-Chahine C,H-ilal-Dandan R.Interleukin-1 beta inhibits Na + -K+-ATP ase activity and protein expression in cardiac myocytes.Cytokine,2004,26:1-8.
8Torre-Amione G,Kapadia S,Benedict C,et al.Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction:a report from the studies of left ventricular dysfunction(SOLVD).J Am Coll cardiol,1996,27:1202-1206.
9Magowan GA,Mann DL,Kormos RL,et al.Circulating interleukin-6 in severe heart failure.AM J cardiol,1997,79:1128-1131.
